InnovAge Holding Corp. Common Stock (INNV)
FairStock Score: 42/100 — MIXED
Key Financials
| Current Price | $9.55 |
| Market Cap | $1.3B |
| P/E Ratio | -477.5 |
| ROE | -0.26% |
| Dividend Yield | —% |
| Sector | Healthcare |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I approach InnovAge as a Graham-style skeptic. The business provides PACE services to seniors, a complex, regulated model that can create local density and switching costs, but the numbers do not yet demonstrate a durable moat. Revenue has grown from $763.9M in FY2024 to $853.7M in FY2025 and $989.7M in FY2026, which is real progress. Yet the company lost money in each of those years: net losses of $21.3M, $30.3M, and $2.5M, with FY2026 EPS of $-0.02. The fiscal Q3 2026 quarter, ended 2026-03-31, showed a $29.5M net loss and $-0.22 EPS, so profitability is choppy. At the 2026-10-13 close of $9.02, FairStock calculations show a negative P/E of -451 on $-0.02 EPS, a P/B of 5.21, and an EV/EBITDA of 47.53. Those are not bargain multiples. The company does generate $50.4M of trailing free cash flow, a 4.1% FCF yield, and carries D/E of 0.32. Its Piotroski F-Score of 7/9 and Altman Z-Score of 2.86 suggest the balance sheet is not immediately distressed. ROE is -0.26% and ROCE 0.67%, so capital returns are barely positive or negative. FairStock's score is 42/100, and its Lynch category is none because of losses in each of the last four years. I would want consistent positive net income, better returns on capital, and a wider margin of safety before calling this a value investment. The price may reflect hope for future PACE expansion rather than present earning power.
In plain English: InnovAge runs a healthcare program for older people, offering clinics, in-home care, and transportation. Revenue is growing and the company came close to break-even in fiscal 2026, but it has still lost money in each of the last four years and profits are thin. At $9.02, the shares look expensive compared with the company's current profits and the value of its assets, even though it produces some free cash flow.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q3 2026 10-Q (period ended 2026-03-31) · fiscal Q2 2026 10-Q (period ended 2025-12-31) · fiscal Q1 2026 10-Q (period ended 2025-09-30) · fiscal Q3 2025 10-Q (period ended 2025-03-31) · FY2026 10-K (period ended 2026-06-30) · FY2025 10-K (period ended 2025-06-30) · FY2024 10-K (period ended 2024-06-30)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer